Jackson Creek Investment Advisors LLC Vir Biotechnology, Inc. Transaction History

Jackson Creek Investment Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$19.08 - $26.7 $402,015 - $562,569	-21,070 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$21.19 - $40.01 $21,062 - $39,769	994 Added 4.95%	21,070 $542,000
Q4 2021 Feb 01, 2022	BUY	$30.97 - $54.03 $621,753 - $1.08 Million	20,076 New	20,076 $841,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.